Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 12 years of age or older at the time of signing up for the trial
- People who have a confirmed diagnosis of Sickle Cell Disease, specifically the HbSS type, or related forms called HbSC or HbSβ-thalassemia, shown by one or more clinical signs or features
- People (or their legal representatives) who are able to provide written consent to participate, and who are able to follow the requirements of the study
Who may not be able to join:
- People who have any condition or health abnormality that, in the trial doctor's judgment, could put the patient's safety at risk or affect the reliability of the study results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amma Owusu-Ansah, MD, University Hospitals Cleveland Medical Center
Phone: (216) 368-6447
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Develop an SCD Biochip with which to examine key cellular properties and interactions, including RBC and WBC cellular, adhesive, and inflammatory properties, and circulating endothelial and hematopoietic precursor cell characteristics.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.